Foreword: Oseltamivir for seasonal, avian and pandemic influenza: 10 years of clinical experience.
作者信息
Nguyen-Van-Tam Jonathan S
机构信息
Division of Epidemiology and Public Health, University of Nottingham, City Hospital, Nottingham, UK.
出版信息
J Antimicrob Chemother. 2010 Apr;65 Suppl 2(Suppl 2):ii3-ii4. doi: 10.1093/jac/dkq033.
Abstract
摘要
相似文献
1
Foreword: Oseltamivir for seasonal, avian and pandemic influenza: 10 years of clinical experience.
J Antimicrob Chemother. 2010 Apr;65 Suppl 2(Suppl 2):ii3-ii4. doi: 10.1093/jac/dkq033.
2
[Oseltamivir-resistant influenza A pandemic (H1N1) 2009 virus].
Ann Fr Anesth Reanim. 2010 Feb;29(2):85-6. doi: 10.1016/j.annfar.2010.01.005.
3
Oseltamivir (Tamiflu) for pandemic influenza in India: some issues.
Natl Med J India. 2009 Mar-Apr;22(2):103.
4
Emerging oseltamivir resistance in seasonal and pandemic influenza A/H1N1.
J Clin Virol. 2011 Oct;52(2):70-8. doi: 10.1016/j.jcv.2011.05.019. Epub 2011 Jun 17.
5
[Use of Tamiflu under pandemic conditions].
Rev Med Suisse. 2009 Jul 15;5(211):1532.
6
Oseltamivir resistance in human seasonal influenza viruses (A/H1N1) in EU and EFTA countries: an update.
Euro Surveill. 2008 Feb 7;13(6):8032.
7
Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses.
Antiviral Res. 2010 Nov;88(2):182-6. doi: 10.1016/j.antiviral.2010.08.010. Epub 2010 Aug 23.
8
Neuraminidase inhibitors and their role in avian and pandemic influenza.
Antivir Ther. 2007;12(4 Pt B):593-602.
9
Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.
Clin Pharmacokinet. 2010 Nov;49(11):741-65. doi: 10.2165/11534730-000000000-00000.
10
Antiviral treatment of patients with oseltamivir-resistant and oseltamivir-susceptible seasonal Influenza A (H1N1) infection during the 2007-2008 influenza season in the United States.
Clin Infect Dis. 2010 Feb 15;50(4):621-2. doi: 10.1086/650178.
引用本文的文献
1
Oseltamivir in seasonal, avian H5N1 and pandemic 2009 A/H1N1 influenza: pharmacokinetic and pharmacodynamic characteristics.
Clin Pharmacokinet. 2010 Nov;49(11):741-65. doi: 10.2165/11534730-000000000-00000.
本文引用的文献
1
Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study.
BMJ. 2009 Dec 10;339:b5213. doi: 10.1136/bmj.b5213.
2
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.
N Engl J Med. 2009 Nov 12;361(20):1935-44. doi: 10.1056/NEJMoa0906695. Epub 2009 Oct 8.
3
Influenza-related hospitalizations among young children in Leicestershire.
Pediatr Infect Dis J. 2003 Oct;22(10 Suppl):S228-30. doi: 10.1097/01.inf.0000092193.91306.2f.
4
Commentary: causes of incidence and causes of cases--a Durkheimian perspective on Rose.
Int J Epidemiol. 2001 Jun;30(3):435-9. doi: 10.1093/ije/30.3.435.
Zotero 插件